Authors: Tavill, AS

Citation: As. Tavill, Diagnosis and management of hemochromatosis, HEPATOLOGY, 33(5), 2001, pp. 1321-1328

Authors: Dodig, M Tavill, AS

Citation: M. Dodig et As. Tavill, Hepatitis C and human immunodeficiency virus coinfections, J CLIN GAST, 33(5), 2001, pp. 367-374

Authors: Di Bisceglie, AM Bonkovsky, HL Chopra, S Flamm, S Reddy, RK Grace, N Killenberg, P Hunt, C Tamburro, C Tavill, AS Ferguson, R Krawitt, E Banner, B Bacon, BR

Citation: Am. Di Bisceglie et al., Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial, HEPATOLOGY, 32(1), 2000, pp. 135-138

Authors: Fontana, RJ Israel, J LeClair, P Banner, BF Tortorelli, K Grace, N Levine, RA Fiarman, G Thiim, M Tavill, AS Bonkovsky, HL

Citation: Rj. Fontana et al., Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial, HEPATOLOGY, 31(3), 2000, pp. 730-736

Authors: Tavill, AS

Citation: As. Tavill, Clinical implications of the hemochromatosis gene, N ENG J MED, 341(10), 1999, pp. 755-757

Authors: Tavill, AS

Citation: As. Tavill, Screening for hemochromatosis: Phenotyping or genotyping or both?, AM J GASTRO, 94(6), 1999, pp. 1430-1433